Evidence map›Paper›PMID 27029289›Full record

ArticleAntibiotics (Basel, Switzerland)2013

The Staphylococcus aureus Membrane Protein SA2056 Interacts with Peptidoglycan Synthesis Enzymes.

Chantal Quiblier, Agnieszka Luczak-Kadlubowska, Esther Holdener, Daniela Alborn, Tanja Schneider, Imke Wiedemann, Mariana G Pinho, Hans-Georg Sahl, Susanne Rohrer, Brigitte Berger-Bächi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Chantal QuiblierInstitute of Medical Microbiology, University of Zurich / Gloriastrasse 32, 8006 Zurich, Switzerland. chantalquiblier@access.uzh.ch.
Agnieszka Luczak-KadlubowskaCentre of Quality Control in Microbiology / ul. Chelmska 30/34, 00-725 Warsaw, Poland. luczakowa@interia.pl.
Esther HoldenerInstitute of Medical Microbiology, University of Zurich / Gloriastrasse 32, 8006 Zurich, Switzerland. esther.holdener@alumni.ethz.ch.
Daniela AlbornInstitute for Medical Microbiology, Immunology and Parasitology, University of Bonn / Meckenheimer Allee 168, 53115 Bonn, Germany. dalborn@uni-bonn.de.
Tanja SchneiderInstitute for Medical Microbiology, Immunology and Parasitology, University of Bonn / Meckenheimer Allee 168, 53115 Bonn, Germany. tanja@mibi03.meb.uni-bonn.de.
Imke WiedemannInstitute for Medical Microbiology, Immunology and Parasitology, University of Bonn / Meckenheimer Allee 168, 53115 Bonn, Germany. iwiedemann@medpharmaservice.de.
Mariana G PinhoInstituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa / Av. Da Républica (EAN), 2781-901 Oeiras, Portugal. mgpinho@itqb.unl.pt.
Hans-Georg SahlInstitute for Medical Microbiology, Immunology and Parasitology, University of Bonn / Meckenheimer Allee 168, 53115 Bonn, Germany. sahl@mibi03.meb.uni-bonn.de.
Susanne RohrerInstitute of Medical Microbiology, University of Zurich / Gloriastrasse 32, 8006 Zurich, Switzerland. susanne_elisabeth.rohrer@alumni.ethz.ch.
Brigitte Berger-BächiInstitute of Medical Microbiology, University of Zurich / Gloriastrasse 32, 8006 Zurich, Switzerland. bberger@imm.uzh.ch.
Maria Magdalena SennInstitute of Medical Microbiology, University of Zurich / Gloriastrasse 32, 8006 Zurich, Switzerland. msenn@imm.uzh.ch.
University of Zurich · CHUniversity of Bonn · DEUniversidade Nova de Lisboa · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The yet uncharacterized membrane protein SA2056 belongs to the ubiquitous RND (Resistance-Nodulation-cell Division) family of transmembrane efflux transporters. The sa2056 gene is located downstream of femX, the gene encoding the essential, non-ribosomal peptidyl-transferase adding the first glycine in the staphylococcal cell wall pentaglycine interpeptide. Due to its proximity to and weak co-transcription with femX, we assumed that sa2056 may somehow be involved in peptidoglycan synthesis. Specific antibodies against SA2056 showed that this protein is expressed during growth and present in the membrane fraction of cell preparations. Using a bacterial two hybrid system, SA2056 was shown to interact (i) with itself, (ii) with FemB, which adds glycines 4 and 5 to the peptidoglycan interpeptide and (iii) with the essential penicillin binding proteins, PBP1 and PBP2, required for cell division and incorporation of the peptidoglycan into the cell wall. Unexpectedly, deletion of sa2056 led to no phenotype regarding growth, antibiotic resistances or cell morphology; nor did sa2056 deletion in combination with femB inactivation alter b-lactam and lysostaphin sensitivity and resistance, respectively, pointing to possible redundancy in the cell wall synthesis pathway. These results suggest an accessory role of SA2056 in S. aureus peptidoglycan synthesis, broadening the range of biological functions of RND proteins.

Indexed as

bacterial two-hybrid systemFemABXPBPpeptidoglycanRND proteinStaphylococcus aureus

Identifiers

PMID27029289
PMCPMC4790295
OpenAlexW2031965635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.